- Home
- TPST vs FCUV Comparison
TPST vs FCUV Comparison
Compare TPST & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- FCUV
- Stock Information
- Founded
- TPST 2011
- FCUV 2012
- Country
- TPST United States
- FCUV United States
- Employees
- TPST N/A
- FCUV N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- TPST Health Care
- FCUV Industrials
- Exchange
- TPST Nasdaq
- FCUV Nasdaq
- Market Cap
- TPST 33.0M
- FCUV 27.6M
- IPO Year
- TPST N/A
- FCUV N/A
- Fundamental
- Price
- TPST $7.76
- FCUV $2.83
- Analyst Decision
- TPST Hold
- FCUV
- Analyst Count
- TPST 3
- FCUV 0
- Target Price
- TPST $30.00
- FCUV N/A
- AVG Volume (30 Days)
- TPST 80.4K
- FCUV 20.5K
- Earning Date
- TPST 08-07-2025
- FCUV 08-13-2025
- Dividend Yield
- TPST N/A
- FCUV N/A
- EPS Growth
- TPST N/A
- FCUV N/A
- EPS
- TPST N/A
- FCUV N/A
- Revenue
- TPST N/A
- FCUV $408,887.00
- Revenue This Year
- TPST N/A
- FCUV N/A
- Revenue Next Year
- TPST N/A
- FCUV N/A
- P/E Ratio
- TPST N/A
- FCUV N/A
- Revenue Growth
- TPST N/A
- FCUV 6.49
- 52 Week Low
- TPST $5.35
- FCUV $1.50
- 52 Week High
- TPST $28.34
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- TPST 63.65
- FCUV 29.91
- Support Level
- TPST $6.11
- FCUV $2.68
- Resistance Level
- TPST $6.49
- FCUV $3.16
- Average True Range (ATR)
- TPST 0.35
- FCUV 0.28
- MACD
- TPST 0.03
- FCUV -0.08
- Stochastic Oscillator
- TPST 100.00
- FCUV 25.38
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.